Clinical trial
Protect II, A Prospective, Multicenter Randomized Controlled Trial
NCT00562016 · Abiomed Inc., Industry · Terminated
Key facts
| NCT number | NCT00562016 |
|---|---|
| Title | Protect II, A Prospective, Multicenter Randomized Controlled Trial |
| Official title | PROTECT II: A Prospective, Multi-center, Randomized Controlled Trial of the IMPELLA RECOVER LP 2.5 System Versus Intra Aortic Balloon Pump (IABP)in Patients Undergoing Non Emergent High Risk PCI |
| Acronym | PROTECT II |
| Lead sponsor | Abiomed Inc., Industry |
| Status | Terminated |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Coronary Artery Disease |
| Intervention type | Device |
| Interventions | IMPLELLA LP 2.5, IABP Intra-aortic balloon pump |
| Enrollment | 452 |
| Start date | Oct 1, 2007 |
| Primary completion | Apr 1, 2011 |
| Completion | Sep 1, 2011 |
| First posted | Nov 21, 2007 |
| Last update posted | Mar 21, 2011 |
| Countries | Canada, Netherlands, United States |
At a glance
- 10–99 Study sites
- No Results posted
- 1–9 Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: